seekingalpha.com
/3 weeks ago
Latest updates for Nktr
Fresh curated links around NKTR are collected here so marketers can spot useful updates and turn timely ideas into posts faster.
Recent items include:
- Nektar Therapeutics (NKTR) Shareholder/Analyst Call - Slideshow
- Nurix: Maintaining 'Strong Buy' Updated Bexobrutideg Data CLL/SLL And Multiple Advancement Pathways
- StockWatch: Nektar Shares Flat as $90M Jury Verdict Less than Sought in Lilly Suit
Post angles to try
Share the most useful takeaway for your audience.
Turn one article into a quick practical checklist.
Ask your audience how this shift affects their work.
Fresh articles and ideas
Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.
seekingalpha.com
/1 week ago
Nurix: Maintaining 'Strong Buy' Updated Bexobrutideg Data CLL/SLL And Multiple Advancement Pathways
genengnews.com
/3 weeks ago
StockWatch: Nektar Shares Flat as $90M Jury Verdict Less than Sought in Lilly Suit
This past week, Nektar Therapeutics (Nasdaq: NKTR) offered an uncommon example of victory in court translating into defeat on Wall Street. Nektar’s shares finished Friday flat, dip...
cafepharma.com
/2 weeks ago
Kiniksa
Kiniksa Anonymous (not verified) Mon, 10/05/2026 - 04:07 field_thread_url https://cafepharma.com/boards/threads/kiniksa.658756/ board na...
cafepharma.com
/1 month ago
Kiniksa
Kiniksa Anonymous (not verified) Thu, 09/17/2026 - 18:54 field_thread_url https://cafepharma.com/boards/threads/kiniksa.658756/ board na...
pharmexec.com
/1 week ago
<
pharmexec.com
/2 weeks ago
<![CDATA[Roundup: TRexBio & Retension Pharmaceuticals Announce IPO Pricing ]]>
seekingalpha.com
/1 month ago
Tyra Biosciences: 'Hold' IR-NMIBC Data September 9th 2026, With Caution Ahead For 2027 Readouts
investing.com
/4 weeks ago
Novo Nordisk licenses Nanexa drug tech in deal worth up to €1.17 bln
pharmexec.com
/1 week ago
<
pharmexec.com
/4 weeks ago
<
prweb.com
/2 weeks ago
Cata-Kor Enters Physical Retail with Target Launch, Bringing Its NADвЃє Longevity Line to Stores Nationwide
Cata-Kor NMN and Liposomal NAD⁺ are now available at Target stores and Target.com nationwide in retail-exclusive 25-serving packs — the brand's first move from e-commerce leade...
biopharmadive.com
/2 weeks ago
TRex Bio prices $117M IPO to support immune drug work
Eli Lilly is the largest equity holder in TRex, which is developing drugs that treat immunological conditions by activating “Treg” cells.
Turn fresh research into a full content calendar
Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.
Sources covering Nktr
seekingalpha.com
Recent coverage from public sources
Public source
cafepharma.com
Recent coverage from public sources
Public source
feeds.feedburner.com
Recent coverage from public sources
Public source
seekingalpha.com
Recent coverage from public sources
Public source
biopharmadive.com
Recent coverage from public sources
Public source
investing.com
Recent coverage from public sources
Public source